<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"	
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Uncategorized &#187; The Doctor&#039;s Channel</title>
	<atom:link href="http://www.thedoctorschannel.com/uncategorized/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thedoctorschannel.com</link>
	<description>Internet TV for Doctors</description>
	<lastBuildDate>Wed, 16 May 2012 23:34:19 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
			<item>
		<title>Hand surgery helpful for RA associated deformities</title>
		<link>http://www.thedoctorschannel.com/view/hand-surgery-helpful-for-ra-associated-deformities/</link>
		<pubDate>Tue, 15 May 2012 18:48:10 +0000</pubDate> 
				<category><![CDATA[Orthopedics]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Rheumatology]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[hand surgery]]></category>
		<category><![CDATA[rheumatoid arthritis]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31791</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; Both hand function and appearance are improved in rheumatoid arthritis (RA) patients with severe deformities treated by silicone metacarpophalangeal joint arthroplasty (SMPA), researchers report in an April 17th on-line paper in Arthritis Care &#038; Research. Dr. Kevin C. Chung and colleagues at The University of Michigan Health System, Ann Arbor -]]></description>
		
			<media:content duration="1:32" medium="video">
		<media:title><![CDATA[Hand surgery helpful for RA associated deformities]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; Both hand function and appearance are improved in rheumatoid arthritis (RA) patients with severe deformities treated by silicone metacarpophalangeal joint arthroplasty (SMPA), researchers report in an April 17th on-line paper in Arthritis Care &#038; Research. Dr. Kevin C. Chung and colleagues at The University of Michigan Health System, Ann Arbor -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/hand-surgery-helpful-for-ra-associated-deformities/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120515clin004.jpg"/>
	<media:keywords><![CDATA[hand surgery,rheumatoid arthritis]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Add-on bevacizumab slows progression of recurrent ovarian cancer</title>
		<link>http://www.thedoctorschannel.com/view/add-on-bevacizumab-slows-progression-of-recurrent-ovarian-cancer-2/</link>
		<pubDate>Wed, 25 Apr 2012 21:43:45 +0000</pubDate> 
				<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Women’s Health]]></category>
		<category><![CDATA[Bevacizumab]]></category>
		<category><![CDATA[carboplatin ovarian cancer]]></category>
		<category><![CDATA[gemcitabine]]></category>
		<category><![CDATA[OCEANS trial]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=30200</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Progression-free survival (PFS) is significantly longer in women with recurrent ovarian cancer when bevacizumab is added to chemotherapy, a multicenter team reports in the Journal of Clinical Oncology online April 23. “As ovarian cancer becomes a chronic illness, treatments that prolong PFS, and therefore time without cytotoxic chemotherapy, become increasingly -]]></description>
		
			<media:content duration="1:18" medium="video">
		<media:title><![CDATA[Add-on bevacizumab slows progression of recurrent ovarian cancer]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Progression-free survival (PFS) is significantly longer in women with recurrent ovarian cancer when bevacizumab is added to chemotherapy, a multicenter team reports in the Journal of Clinical Oncology online April 23. “As ovarian cancer becomes a chronic illness, treatments that prolong PFS, and therefore time without cytotoxic chemotherapy, become increasingly -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/add-on-bevacizumab-slows-progression-of-recurrent-ovarian-cancer-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120425drgd005.jpg"/>
	<media:keywords><![CDATA[Bevacizumab,carboplatin ovarian cancer,gemcitabine,OCEANS trial]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Noradrenaline a cost-effective option for type 1 hepatorenal syndrome</title>
		<link>http://www.thedoctorschannel.com/view/noradrenaline-a-cost-effective-option-for-type-1-hepatorenal-syndrome/</link>
		<pubDate>Tue, 21 Feb 2012 22:30:28 +0000</pubDate> 
				<category><![CDATA[Critical Care]]></category>
		<category><![CDATA[Gastroenterology]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[hepatorenal syndrome]]></category>
		<category><![CDATA[noradrenaline]]></category>
		<category><![CDATA[terlipressin]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=25246</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – For reversal of type 1 hepatorenal syndrome, treatment with noradrenaline seems to work as well as terlipressin and is a lot less expensive, researchers from India report. Hepatorenal syndrome, or HRS, is a form of renal failure seen in patients with end-stage liver disease. Splanchnic and systemic vasodilation together with -]]></description>
		
			<media:content duration="01:50" medium="video">
		<media:title><![CDATA[Noradrenaline a cost-effective option for type 1 hepatorenal syndrome]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – For reversal of type 1 hepatorenal syndrome, treatment with noradrenaline seems to work as well as terlipressin and is a lot less expensive, researchers from India report. Hepatorenal syndrome, or HRS, is a form of renal failure seen in patients with end-stage liver disease. Splanchnic and systemic vasodilation together with -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/noradrenaline-a-cost-effective-option-for-type-1-hepatorenal-syndrome/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/02/Thumbnail_20120221drgd004.jpg"/>
	<media:keywords><![CDATA[hepatorenal syndrome,noradrenaline,terlipressin]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
	</channel>
</rss>
